SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-020568
Filing Date
2023-06-08
Accepted
2023-06-08 16:15:43
Documents
84
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 880342
2 ex31-1.htm EX-31.1 17503
3 ex31-2.htm EX-31.2 17510
4 ex32-1.htm EX-32.1 6522
5 ex32-2.htm EX-32.2 6496
  Complete submission text file 0001493152-23-020568.txt   5665422

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20230331.xsd EX-101.SCH 49662
7 XBRL CALCULATION FILE vvos-20230331_cal.xml EX-101.CAL 66732
8 XBRL DEFINITION FILE vvos-20230331_def.xml EX-101.DEF 189274
9 XBRL LABEL FILE vvos-20230331_lab.xml EX-101.LAB 376885
10 XBRL PRESENTATION FILE vvos-20230331_pre.xml EX-101.PRE 313901
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 834917
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 231002103
SIC: 3841 Surgical & Medical Instruments & Apparatus